(Q28276621)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305887%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305887%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

0 references

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305887%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Anna Novials

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305887%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

4

Drzewoski J

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305887%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Schernthaner G

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305887%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Grimaldi A

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305887%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Di Mario U

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305887%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Kempler P

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305887%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Rottiers R

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305887%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Rutten GE

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305887%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Shaw KM

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305887%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

English

0 references

publication date

1 August 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305887%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Investigation

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305887%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305887%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305887%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

535-542

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305887%20AND%20SRC:MED&resulttype=core&format=json

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01381.X

Hypoglycaemia unawareness and the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01381.X

Diamicron MR once daily is effective and well tolerated in type 2 diabetes: a double-blind, randomized, multinational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01381.X

Gliclazide modified release: A critical review of pharmacodynamic, metabolic, and vasoprotective effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01381.X

Rates of hypoglycemia in users of sulfonylureas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01381.X

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01381.X

Hormonal counterregulation and consecutive glimepiride serum concentrations during severe hypoglycaemia associated with glimepiride therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01381.X

Pharmacokinetics and safety of glimepiride at clinically effective doses in diabetic patients with renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01381.X

Differential sensitivity of beta-cell and extrapancreatic K(ATP) channels to gliclazide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01381.X

Effects of glimepiride and glibenclamide on insulin and glucagon secretion by the perfused rat pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01381.X

10.1111/J.1365-2362.2004.01381.X

21 January 2018

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

2246895

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305887%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

2246895

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

2246895